Poliovaccine strategy.
作者信息
Johnstone T
出版信息
Lancet. 1985 Mar 23;1(8430):695. doi: 10.1016/s0140-6736(85)91352-2.
PMID:2858638
Abstract
摘要
相似文献
1
Poliovaccine strategy.
Lancet. 1985 Mar 23;1(8430):695. doi: 10.1016/s0140-6736(85)91352-2.
2
Poliovaccine strategy.脊髓灰质炎疫苗策略
Lancet. 1985 Feb 2;1(8423):285-6.
3
Poliovaccine.脊髓灰质炎疫苗
Lancet. 1983 May 7;1(8332):1022-23.
4
Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovaccine campaign.在全国范围口服脊髓灰质炎疫苗运动期间对免疫功能低下儿童的脊髓灰质炎预防
Pediatr Infect Dis J. 1987 Dec;6(12):1106-10.
5
Reassessment of the place of inactivated poliomyelitis vaccine in national immunization programmes.
Dev Biol Stand. 1981;47:275-82.
6
[Vaccination against poliomyelitis in France. 1983 experience and new trends].
Ann Pediatr (Paris). 1984 Jun;31(6):471-5.
7
Poliomyelitis in the Netherlands before and after vaccination with inactivated poliovaccine.荷兰使用灭活脊髓灰质炎疫苗前后的脊髓灰质炎情况
J Hyg (Lond). 1967 Dec;65(4):547-57. doi: 10.1017/s0022172400046076.
8
Perils of switch to inactivated poliovaccine.更换为灭活脊髓灰质炎疫苗的风险。
Lancet. 1990 May 19;335(8699):1219-20. doi: 10.1016/0140-6736(90)92739-5.
9
The immunological response of Nigerian infants to attenuated and inactivated poliovaccines.尼日利亚婴儿对减毒和灭活脊髓灰质炎疫苗的免疫反应。
Ann Trop Med Parasitol. 1978 Apr;72(2):111-5. doi: 10.1080/00034983.1978.11719290.
10
Vaccination against poliomyelitis: present possibilities and future prospects.脊髓灰质炎疫苗接种：当前可能性与未来前景
Am J Public Health. 1988 Mar;78(3):304-5. doi: 10.2105/ajph.78.3.304.
引用本文的文献
1
Versatile cobalt-catalyzed regioselective chain-walking double hydroboration of 1,n-dienes to access gem-bis(boryl)alkanes.多功能钴催化 1,n-二烯的区域选择性链行走双硼氢化反应，以获得偕二硼基烷烃。
Nat Commun. 2020 Feb 7;11(1):765. doi: 10.1038/s41467-020-14543-2.
Zotero 插件